View Brainstorm Cell Therapeutics Inc. BCLI investment & stock information. Get today's Brainstorm Cell Therapeutics Inc stock price and latest BCLI news as well as Brainstorm Cell Therapeutics real-time stock quotes, technical analysis, full financials and more. The share float percentage for the stock currently stands at 28.45%. Brainstorm Cell Therapeutics Inc. (NASDAQ:BCLI) went down by -66.50% from its latest closing price compared to the recent 1-year high of $17.95. According to present data Brainstorm Cell Therapeutics's BCLI shares and potentially its market environment have been in a bullish cycle in the last 12 months (if exists). Shares of BrainStorm Cell Therapeutics (NASDAQ:BCLI) fell off a cliff Tuesday, and were down by 67% as of 12:20 p.m. EST after being down by as much as â¦ Brainstorm Cell Therapeutics Inc. Common Stock (BCLI) Stock Quotes - Nasdaq offers stock quotes & market activity data for US and global markets. The company stock has a Forward Dividend ratio of 0, while the dividend yield is 0. There are 108 institutions holding the Brainstorm Cell Therapeutics Inc. stock share, with Blackrock Inc. the top institutional holder. Brainstorm Cell Therapeutics Inc., which has a market valuation of $163.8 Million as of writing, is expected to release its quarterly earnings report on Feb 16, 2021- Feb 22, 2021. Brainstorm Cell Therapeutics Inc. (NASDAQ:BCLI) went down by -4.33% from its latest closing price compared to the recent 1-year high of $17.95. Wall Street Stock Market & Finance report, prediction for the future: You'll find the Brainstorm Cell Therapeutics share forecasts, stock quote and buy / sell signals below. BCLI: Get the latest Brainstorm Cell Therapeutics stock price and detailed information including BCLI news, historical charts and realtime prices. As of Sep 29, 2020, the company held 5.93% of the shares, roughly 1.87 Million BCLI shares worth $31.69 Million. Post-Market 0.00 (0.00%) Brainstorm Cell Therapeutics Inc. is a biotechnology company. Brainstorm Cell Therapeutics Inc. BCLI 5.20 0.12 (2.26%). Get the hottest stocks to trade every â¦ On the other hand, the stock is +45.39% away from its low in the 90-day period. Get the latest Brainstorm Cell Therapeutics Inc. BCLI detailed stock quotes, stock â¦ A recent spot check on the stockâs support and resistance revealed that the publicly-traded Brainstorm Cell Therapeutics Inc. (NASDAQ: BCLI) shares are trading at a price close to -69.22% lower than its 90-day high. The Company is engaged in developing adult stem cell therapies for debilitating neurodegenerative disorders, such as Amyotrophic Lateral Sclerosis (ALS, also known as Lou Gehrig's disease), Multiple Sclerosis (MS) and Parkinson's disease (PD), among others. Press Release reported 3 hours ago that BrainStorm Announces Topline Results from NurOwn(R) Phase 3 ALS Study. Press Release reported on 11/23/20 that BrainStorm to present NurOwn(R) Phase 3 Clinical Trial Results at 31st International Symposium on ALS/MND The companyâs stock price has collected -0.09% of loss in the last five trading sessions. The companyâs stock price has collected 4.46% of gains in the last five trading sessions.